ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: MyHC-beta; MyHC-slow; Myosin heavy chain cardiac muscle beta isoform; Myosin heavy chain slow isoform; Myosin-7
Storage: 2-8C
Application: ELISA Analysis: 0.5 μg/mL from a representative lot of Anti-Myosin Heavy Chain 7, clone 1B19 ZooMAb Rabbit Monoclonal detected Myosin Heavy Chain 7, but not any other peptide from 6 other proteins.Immunohistochemistry (Paraffin) Analysis: A 1:100-1,000 dilution from a representative lot detected Myosin Heavy Chain 7 in human skeletal muscle and mouse skeletal muscle tissue sections.Affinity Binding Assay: A representative lot of this antibody bound Myosin Heavy Chain 7 with a KD value of 2.51 x 10-7 in an affinity binding assay. Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany